Skip to main content

Fit for purpose frozen tissue collections by RNA integrity number-based quality control assurance at the Erasmus MC tissue bank.

Kap M, Oomen M, Arshad S, de Jong B, Riegman P

Publication: Biopreserv Biobank (2014) • Vol 12 • Page 81-90PMID: 24749874View on PubMed

Purpose

The purpose of this paper was to assess the RNA quality of biobanked tissue specimens collected and stored at different institutions. RNA integrity numbers (RIN) were compared for specimens that differed in tissue type, procurement method, cryopreservation method, storage temperature and storage duration.  

Conclusion

When specimens were grouped by RIN, they observed large differences in distribution patterns between biobanks. The percentage of specimens with a RIN less than 5 ranged between 0 and 20.8%, those with a RIN between 5 and 6 ranged between 0 and 8.33%, those with a RIN between 6 and 8 ranged between 25 and 59%, and those with a RIN greater than or equal to 8 ranged between 39 and 45% depending on the biobank.  Biopsies from the Clinical Pathology Frozen Biopsy Archive Collection had the broadest distribution.  Statistical analysis failed to reveal any significant differences in RIN between specimens that differed in collection method, storage temperature, and storage duration.  The potential impact of other variables, such as cold ischemia time, transport conditions, tissue type, and diagnosis were not assessed.

Studies (1)

Purpose

The purpose of this study was to assess and compare the quality of RNA isolated from biobanked tissue specimens collected and stored by four different biobanking institutions (the number of specimens is indicated within parentheses): Erasmus Medical Center Tissue Bank (103), Cancer Institute Archive Collection (48), Liver Sample Archive Collection (123), and the Clinical Pathology Biopsy Archive Collection (24). RIN data was grouped and represented as the percentage of specimens that met fit-for-purpose thresholds identified using literature evidence.  The fit-for-purpose criteria applied were as follows: RIN< 5, not reliable for downstream analysis; 5≤RIN<6, suitable for RT-qPCR;  6≤RIN<8, suitable for RT-qPCR and gene expression array; RIN≥8, suitable for all downstream analyses. RINs from specimens that differed in tissue type, diagnosis, procurement method, cold ischemia time, cryopreservation method, storage temperature and duration were compared.  Tissue specimens with low RNA yields or that showed evidence of morphological degradation were excluded from analysis, although the threshold of RNA yield used by the authors was not specified.

Summary of Findings

The number of specimens that were excluded from analysis due to low RNA yield or evidence of morphological degradation was as follows: 9.68% (9) out of the 103 specimens from the Eramus Medical Center Tissue Bank; 18.75% (9) out of the 48 specimens from the Cancer Institute Archive Collection; 9.8% (12) out of the 123 specimens from the Liver Sample Archive Collection;  20.83% (5) out of the 24 specimens from the Clinical Pathology Frozen Biopsy Archive Collection.  When specimens were grouped by RIN, they observed large differences in distribution patterns between biobanks. The percentage of specimens with a RIN less than 5 ranged between 0 and 20.8%, those with a RIN between 5 and 6 ranged between 0 and 8.33%, those with a RIN between 6 and 8 ranged between 25 and 59%, and those with a RIN greater than or equal to 8 ranged between 39 and 45% depending on the biobank.  Biopsies from the Clinical Pathology Frozen Biopsy Archive Collection had the broadest distribution, as the largest percentage of specimens having both the lowest and highest RIN were from this biobank.  Statistical analysis failed to reveal any significant differences in RIN between specimens that differed in collection method, storage temperature, and storage duration.  However, the authors note that while specimens from the Clinical Pathology Frozen Biopsy Archive Collection had a cold ischemia time of 30 min or less there is no information available on the condition of the specimens during transportation to the pathology laboratory. The potential impact of other variables on RIN distribution, such as cold ischemia time, transport conditions, tissue type, and diagnosis were not assessed.

  • Biospecimens

    TissueAdrenal Gland
    TissueBladder
    TissueBreast
    TissueCervix
    TissueColorectal
    TissueEsophagus
    TissueBone
    TissueEye
    TissueGall Bladder
    TissueKidney
    TissueLarynx
    TissueLiver
    TissueLung
    TissueLymph Node
    TissueNasopharynx
    TissueOvary
    TissuePancreas
    TissueSalivary Gland
    TissueProstate
    TissueSkin
    TissueSmall Bowel
    TissueSpleen
    TissueStomach
    TissueTestis
    TissueThymus Gland
    TissueThyroid Gland
    TissueTongue
    TissueTonsil
    TissueFallopian Tube
    TissueUterus
    TissueVulva
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
    NeoplasticCarcinoma
    NeoplasticBenign
    Cirrhosis
    Hepatitis
  • Platforms

    RNAAutomated electrophoresis/Bioanalyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionCold ischemia time
    30 min to 2 h
    30 min- several hours
    5-30 min
    <30 min
    Biospecimen AcquisitionMethod of tissue acquisition
    Biopsy
    Surgical resection
    Biospecimen PreservationCooling or freezing method/ rate
    Liquid nitrogen
    Pre-cooled isopentane
    StorageStorage duration
    1 y
    13 y
    15 y
    > 20 y
    StorageStorage temperature
    -80°C
    Liquid nitrogen